Risk factors associated with osteoradionecrosis-Reference-Cited by-同舟云学术

Risk factors associated with osteoradionecrosis

Published:2021-01-12 Issue:3 Volume:14 Page:227-235
ISSN:1752-2471
Container-title:Oral Surgery
language:en
Short-container-title:Oral Surg

Author:

Habib Saad¹,Sassoon Isabel²,Thompson Ian³,Patel Vinod⁴^ORCID

Affiliation:

1. Barts and the LondonRoyal London Dental Hospital London UK

2. Computer Science Department Brunel University London Uxbridge UK

3. Oral Clinical & Translational Science. Guys Dental Hospital London UK

4. Oral Surgery (Consultant), Fl 23 Guys Dental Hospital London UK

Publisher

Wiley

Subject

Oral Surgery,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ors.12597

Reference50 articles.

1. RCS.The Oral Management of Oncology Patients Requiring Radiotherapy Chemotherapy and/or Bone Marrow Transplantation.2019. Retrieved fromhttps://www.rcseng.ac.uk/-/media/files/rcs/fds/publications/rcs-oncology-guideline-update%2013v36.pdf.

2. RD‐UK.Predicting and Managing Oral and Dental Complications of Surgical and Non‐Surgical Treatment for Head and Neck Cancer ‐ A Clinical Guideline.2016. Retrieved fromhttps://www.restdent.org.uk/uploads/RD‐UK%20H%20and%20N%20guideline.pdf.

3. Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit experience

4. Infectious diseases of the jaws;Meyer I;J Oral Surg,1970

5. A new concept in the treatment of osteoradionecrosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment;2024-08-20

2. Risk factors associated with the development of osteoradionecrosis (ORN) in Head and Neck cancer patients in Ireland: A 10-year retrospective review;Radiotherapy and Oncology;2024-07

3. Osteoradionecrosis Rates After Head and Neck Radiation Therapy: Beyond the Numbers;Practical Radiation Oncology;2024-07

4. The use of pentoxifylline within the medical regime for the management and prevention of osteoradionecrosis in patients with cardiac‐, cerebrovascular and thromboembolic conditions;Oral Surgery;2024-01-03

5. The management of osteoradionecrosis in palliative head and neck cancer patients;Oral Surgery;2024-01